Thursday, January 17, 2013
Publication and contact
Direct conversion of
quiescent cardiomyocytes into pacemaker cells
gene therapy approach for direct conversion of quiescent cardiomyocytes into
pacemaker cells could be useful for treating arrhythmias. In cultured rat
ventricular myocytes, adenoviral vector expression of T-box
18 (Tbx18) resulted in the formation
of monolayers of spontaneously beating cells. In guinea pigs, cardiac
injection of the adenovirus vector encoding Tbx18 led to pacemaker
activity at the site of injection, whereas injection of the same vector
encoding a control protein did not. Next steps include validating the results
in a large animal model and evaluating the safety and pharmacokinetics of the
Published online Jan. 17, 2013
Patent and licensing status
Kapoor, N. et al. Nat.
Biotechnol.; published online Dec. 16, 2012;
Contact: Eduardo Marbán,
Cedars-Sinai Medical Center,
Los Angeles, Calif.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]